Biodesix Inc. (BDSX) Tops Q4 EPS by 1c

Biodesix Inc. (NASDAQ: BDSX) reported Q4 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $20.42 million versus the consensus estimate of $19.87 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Evaxion posts $3.7M Q2 loss, advances cancer vaccine pipeline
• Navios Maritime Partners (NMM) Tops Q2 EPS by 34c